相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Protein tyrosine phosphatase 4A3 (PTP4A3/PRL-3) drives migration and progression of T-cell acute lymphoblastic leukemia in vitro and in vivo
M. Wei et al.
ONCOGENESIS (2020)
Protein tyrosine phosphatases: promising targets in pancreatic ductal adenocarcinoma
Mariana Tannus Ruckert et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2019)
PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein
Min Thura et al.
NATURE COMMUNICATIONS (2019)
Phosphatase of regenerating liver-3 is expressed in acute lymphoblastic leukemia and mediates leukemic cell adhesion, migration and drug resistance
Magnus A. Hjort et al.
ONCOTARGET (2018)
Targeting ovarian cancer and endothelium with an allosteric PTP4A3 phosphatase inhibitor
Kelley E. McQueeney et al.
Oncotarget (2018)
Targeting phosphatases of regenerating liver (PRLs) in cancer
Min Wei et al.
PHARMACOLOGY & THERAPEUTICS (2018)
PRL-3 is a potential glioblastoma prognostic marker and promotes glioblastoma progression by enhancing MMP7 through the ERK and JNK pathways
Nan Mu et al.
THERANOSTICS (2018)
PTP4A3 is a target for inhibition of cell proliferatin, migration and invasion through Akt/mTOR signaling pathway in glioblastoma under the regulation of miR-137
Liling Wang et al.
BRAIN RESEARCH (2016)
Allosteric Modulation of Phosphatase Activity May Redefine Therapeutic Value
Joseph M. Salamoun et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Phosphatase of regenerating liver 3 (PRL-3) is overexpressed in human prostate cancer tissue and promotes growth and migration
Esten N. Vandsemb et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2016)
Increased PTP1B expression and phosphatase activity in colorectal cancer results in a more invasive phenotype and worse patient outcome
Elmer Hoekstra et al.
ONCOTARGET (2016)
Protein tyrosine phosphatase PTP4A1 promotes proliferation and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma via the PI3K/AKT pathway
Long-Zi Liu et al.
ONCOTARGET (2016)
PRL3-zumab, a first-in-class humanized antibody for cancer therapy
Min Thura et al.
JCI INSIGHT (2016)
PTP4A3 Independently Predicts Metastasis and Survival in Upper Tract Urothelial Carcinoma Treated with Radical Nephroureterectomy
Hsin-Chih Yeh et al.
JOURNAL OF UROLOGY (2015)
The protein tyrosine phosphatase PRL-2 interacts with the magnesium transporter CNNM3 to promote oncogenesis
S. Hardy et al.
ONCOGENE (2015)
Independent Oncogenic and Therapeutic Significance of Phosphatase PRL-3 in FLT3-ITD-Negative Acute Myeloid Leukemia
Shuang Qu et al.
CANCER (2014)
Biochemical evaluation of virtual screening methods reveals a cell-active inhibitor of the cancer-promoting phosphatases of regenerating liver
Birgit Hoeger et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2014)
Phosphatase of regenerating liver: a novel target for cancer therapy
Amanda M. Campbell et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2014)
MicroRNA-26a inhibits cell proliferation and invasion of cervical cancer cells by targeting protein tyrosine phosphatase type IVA 1
Jing Dong et al.
MOLECULAR MEDICINE REPORTS (2014)
Identification of PRL1 as a novel diagnostic and therapeutic target for castration-resistant prostate cancer by the Escherichia coli ampicillin secretion trap (CAST) method
Shunsuke Shinmei et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2014)
Oncogenic function and prognostic significance of protein tyrosine phosphatase PRL-1 in hepatocellular carcinoma
Shaowen Jin et al.
ONCOTARGET (2014)
Upregulation of Protein Tyrosine Phosphatase Type IVA Member 3 (PTP4A3/PRL-3) is Associated with Tumor Differentiation and a Poor Prognosis in Human Hepatocellular Carcinoma
Abudureheman Mayinuer et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Oncogenic roles of PRL-3 in FLT3-ITD induced acute myeloid leukaemia
Jung Eun Park et al.
EMBO MOLECULAR MEDICINE (2013)
Molecular mechanisms of the PRL phosphatases
Pablo Rios et al.
FEBS JOURNAL (2013)
Discovery of RG7388, a Potent and Selective p53-MDM2 Inhibitor in Clinical Development
Qingjie Ding et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Ligand Binding Reduces Conformational Flexibility in the Active Site of Tyrosine Phosphatase Related to Biofilm Formation A (TpbA) from Pseudomonas aeruginosa
Dorothy Koveal et al.
JOURNAL OF MOLECULAR BIOLOGY (2013)
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Andrew J. Souers et al.
NATURE MEDICINE (2013)
Targeted Deletion of the Metastasis-Associated Phosphatase Ptp4a3 (PRL-3) Suppresses Murine Colon Cancer
Mark W. Zimmerman et al.
PLOS ONE (2013)
Conformational Motions Regulate Phosphoryl Transfer in Related Protein Tyrosine Phosphatases
Sean K. Whittier et al.
SCIENCE (2013)
The pro-metastasis tyrosine phosphatase, PRL-3 (PTP4A3), is a novel mediator of oncogenic function of BCR-ABL in human chronic myeloid leukemia
Jianbiao Zhou et al.
MOLECULAR CANCER (2012)
Tyrosine phosphatase SHP2 promotes breast cancer progression and maintains tumor-initiating cells via activation of key transcription factors and a positive feedback signaling loop
Nicola Aceto et al.
NATURE MEDICINE (2012)
Metastasis-associated phosphatase PRL-2 regulates tumor cell migration and invasion
Y. Wang et al.
ONCOGENE (2012)
Retroviral Integration Mutagenesis in Mice and Comparative Analysis in Human AML Identify Reduced PTP4A3 Expression as a Prognostic Indicator
Renee Beekman et al.
PLOS ONE (2011)
PRL-3 facilitates angiogenesis and metastasis by increasing ERK phosphorylation and up-regulating the levels and activities of Rho-A/C in lung cancer
Jian Ming et al.
PATHOLOGY (2009)
Prognostic Significance of Phosphatase of Regenerating Liver-3 Expression in Ovarian Cancer
Tingting Ren et al.
PATHOLOGY & ONCOLOGY RESEARCH (2009)
Expression of phosphatase regenerating liver 3 is an independent prognostic indicator for gastric cancer
Ni Da et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
PRL PTPs: mediators and markers of cancer progression
Darrell C. Bessette et al.
CANCER AND METASTASIS REVIEWS (2008)
PRL-3 siRNA inhibits the metastasis of B16-BL6 mouse melanoma cells in vitro and in vivo
Feng Qian et al.
MOLECULAR MEDICINE (2007)
Inhibition of PRL-3 gene expression in gastric cancer cell line SGC7901 via microRNA suppressed reduces peritoneal metastasis
Zhengrong Li et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Synthesis and biological evaluation of rhodanine derivatives as PRL-3 inhibitors
JH Ahn et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Catalytic domain of PRL-3 plays an essential role in tumor metastasis - Formation of PRL-3 tumors inside the blood vessels
K Guo et al.
CANCER BIOLOGY & THERAPY (2004)
A phosphatase associated with metastasis of colorectal cancer
S Saha et al.
SCIENCE (2001)
分享论文
